390 related articles for article (PubMed ID: 18421276)
1. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
[TBL] [Abstract][Full Text] [Related]
2. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
Müssig K; Remer T; Fritsche A; Häring HU; Maser-Gluth C
Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
[TBL] [Abstract][Full Text] [Related]
3. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
[TBL] [Abstract][Full Text] [Related]
4. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
5. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
Hoshiro M; Ohno Y; Masaki H; Iwase H; Aoki N
Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
[TBL] [Abstract][Full Text] [Related]
7. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
[TBL] [Abstract][Full Text] [Related]
8. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
Zhai X; Chen F; Zhu C; Lu Y
J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
[TBL] [Abstract][Full Text] [Related]
9. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
10. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
Yokokawa A; Takasaka T; Shibasaki H; Kasuya Y; Kawashima S; Yamada A; Furuta T
Steroids; 2012 Oct; 77(12):1291-7. PubMed ID: 22850318
[TBL] [Abstract][Full Text] [Related]
11. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
[TBL] [Abstract][Full Text] [Related]
12. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children.
Remer T; Maser-Gluth C; Boye KR; Hartmann MF; Heinze E; Wudy SA
Steroids; 2006 Jul; 71(7):591-8. PubMed ID: 16616286
[TBL] [Abstract][Full Text] [Related]
13. Daily urinary free cortisol and cortisone excretion is associated with urine volume in healthy children.
Shi L; Maser-Gluth C; Remer T
Steroids; 2008 Dec; 73(14):1446-51. PubMed ID: 18762206
[TBL] [Abstract][Full Text] [Related]
14. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
Palermo M; Shackleton CH; Mantero F; Stewart PM
Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
[TBL] [Abstract][Full Text] [Related]
15. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.
Stiefel P; García-Morillo JS; Jimenez L; Pamies E; Miranda ML; Carneado J; Villar J; Leal-Cerro A
Endocrine; 2002 Aug; 18(3):279-84. PubMed ID: 12450320
[TBL] [Abstract][Full Text] [Related]
16. HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids.
Główka FK; Kosicka K; Karaźniewicz-Łada M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):283-9. PubMed ID: 20018571
[TBL] [Abstract][Full Text] [Related]
17. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
[TBL] [Abstract][Full Text] [Related]
20. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
Kerstens MN; Riemens SC; Sluiter WJ; Pratt JJ; Wolthers BG; Dullaart RP
Clin Endocrinol (Oxf); 2000 Apr; 52(4):403-11. PubMed ID: 10762282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
